tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
APRE
Aprea Therapeutics
RESEARCH TOOLSreports

Aprea Therapeutics (APRE) Financial Statements

500 Followers

Aprea Therapeutics Financial Overview

Aprea Therapeutics's market cap is currently $8.04M. The company's EPS TTM is $-0.32; its P/E ratio is -0.67; Aprea Therapeutics is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 285.76K$ 1.50M$ 583.23K$ 0.00$ 0.00
Gross Profit$ 264.04K$ -7.86M$ 576.18K$ -16.40M$ -271.68K
Operating Income$ -13.23M$ -14.32M$ -15.47M$ -113.39M$ -37.45M
EBITDA$ -13.23M$ -14.30M$ -14.28M$ -37.37M$ -36.86M
Net Income$ -12.60M$ -12.96M$ -14.29M$ -112.66M$ -36.54M
Balance Sheet
Cash & Short-Term Investments$ 14.60M$ 22.85M$ 21.61M$ 28.79M$ 53.08M
Total Assets$ 15.93M$ 23.98M$ 22.65M$ 30.16M$ 56.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 190.47K
Net Debt$ -14.60M$ -22.85M$ -21.61M$ -28.79M$ -52.89M
Total Liabilities$ 3.49M$ 4.67M$ 4.39M$ 4.51M$ 7.32M
Stockholders' Equity$ 12.44M$ 19.31M$ 18.26M$ 25.64M$ 49.51M
Cash Flow
Free Cash Flow$ -12.89M$ -13.57M$ -12.27M$ -25.01M$ -37.69M
Operating Cash Flow$ -12.89M$ -13.56M$ -12.18M$ -25.01M$ -37.69M
Investing Cash Flow$ 0.00$ -15.48K$ -93.09K$ 0.00$ 0.00
Financing Cash Flow$ 4.64M$ 14.82M$ 5.14M$ 682.97K$ 1.75M
Currency in USD

Aprea Therapeutics Earnings and Revenue History

Income Statement >

Aprea Therapeutics Debt to Assets

Balance Sheet >

Aprea Therapeutics Cash Flow

Cash Flow >

Aprea Therapeutics Forecast EPS vs Actual EPS

Earnings >